Dose 1 of BMN 331
331-201
Phase 2 gene_therapy active
Quick answer
Dose 1 of BMN 331 for Hereditary Angioedema is a Phase 2 program (gene_therapy) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Hereditary Angioedema
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active